|
INTRODUCTION
CHILDREN'S CORNER
ADULTS CORNER
WANT TO KNOW MORE?
As contrasted with Researchers Corner, which contains medical information gleaned from medical studies and literature, Patients Corner contains significant information gleaned from patients, concerning the current practice of endocrine and metabolic medicine as it relates to adults and parents of children with disorders of growth, growth hormone, and related endocrine issues.
Patients Corner is focused on the diagnosis and treatment of the individual patient; whereas Researchers Corner is focused on the development of evidence-based medicine from which to derive standard criteria for diagnosis and treatment.
Patients Corner captures practical information, which may not not yet be published, for immediate use by patients for discussion with their endocrinologists. It is anticipated that entries to this page will be intermittent and relatively sparse; but, that the content of the page will be noteworthy.
By nature, the content of Patients Corner may be anecodotal and not applicable to other patients. The accounts of diagnsosis and treatment may be inaccurate; or may work out without any fault involved. No identity or contact information is disclosed or published.
iIf you are or a parent of a child who is a patient;, or are an adult patient; and, have an account relating to the diagnosis or treatment of a disorder of growth, growth hormone, or related endocrine issue, which you believe is new or novel, please submit it the Webmaster for review and consideration for publication in Patients Corner at the discretion of the Webmaster. All contact and source information confidential and held in strict confidence; and, none will be published. However, please do not submt any account that includes a complaint of any kind because it will not considered or published on this Website. Publication is within the sole descretion of the Webmaster and HGF.
Use of Arimidex in Puberty
Pediatric endocrinolgist extended the use of Arimidex (anastrozole), an aromatase inhibitor (AI), beyond 2.5 years for a short period of time, with close monitoring. The reason for its use beyond one to two years was based on significant rate of growth with rhGH, and absence of any signs or symptoms that suggest any adverse event arising from its use.
The purpose of using an AI is to (1) suppress acceleration of bone age and fusion of the epiphyses and growth plates of the skeletal long bones, and (2) allow the development of secondary sex characteristics in males, while at the same time suppressing estradiol. Estradiol is an estrogen, which causes acceleration of bone age and fusion of the epiphysis and growth plates, thus advancing the end of puberty in boys and girls (published January 27, 2008).
(No entries)
Do you wish additional information, want the information you have read explained, or desire to know how it applies to your child, or to you, an adult? Join the HGF Peds Discussion Forum or the HGF Adults Discussion Forum, respectively. |
